Cargando…

Overview of Trop-2 in Cancer: From Pre-Clinical Studies to Future Directions in Clinical Settings

SIMPLE SUMMARY: Trophoblast cell surface antigen-2 (Trop-2) is a widely expressed glycoprotein on a variety of different tumours. Trop-2 is considered as a marker of germ cells and is associated with regenerative ability in several tissues. Some studies demonstrated both oncogenic and tumour suppres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lombardi, Pasquale, Filetti, Marco, Falcone, Rosa, Altamura, Valeria, Paroni Sterbini, Francesco, Bria, Emilio, Fabi, Alessandra, Giannarelli, Diana, Scambia, Giovanni, Daniele, Gennaro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046386/ https://www.ncbi.nlm.nih.gov/pubmed/36980630 http://dx.doi.org/10.3390/cancers15061744

Ejemplares similares

Oncologic Drugs Approval in Europe for Solid Tumors: Overview of the Last 6 Years
por: Falcone, Rosa, et al.
Publicado: (2022)

Clinical and mutational profile of AT-rich interaction domain 1A-mutated cancers
por: Falcone, Rosa, et al.
Publicado: (2023)

Molecular Profile and Matched Targeted Therapy for Advanced Breast Cancer Patients
por: Falcone, Rosa, et al.
Publicado: (2023)

Breast Cancer Drug Approvals Issued by EMA: A Review of Clinical Trials
por: Duranti, Simona, et al.
Publicado: (2021)

The likelihood of being helped or harmed as a patient-centred tool to assess cyclin dependent kinase 4/6 inhibitors clinical impact and safety in metastatic breast cancer: a systematic review and sensitivity-analysis
por: Mastrantoni, Luca, et al.
Publicado: (2023)

Targeting targeted agents: open issues for clinical trial design
por: Bria, Emilio, et al.
Publicado: (2009)

Clinicopathologic significance of TROP2 and phospho-TROP2 in gastric cancer
por: Kushiyama, Shuhei, et al.
Publicado: (2021)

Trop-2 Is a Determinant of Breast Cancer Survival
por: Ambrogi, Federico, et al.
Publicado: (2014)

Development of a Digital Research Assistant for the Management of Patients’ Enrollment in Oncology Clinical Trials within a Research Hospital
por: Cesario, Alfredo, et al.
Publicado: (2021)

Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: meta-analysis of randomized clinical trials
por: Loupakis, Fotios, et al.
Publicado: (2010)

Trop2 and its overexpression in cancers: regulation and clinical/therapeutic implications
por: Shvartsur, Anna, et al.
Publicado: (2015)

Trop petits pour Dieu /
por: Laederach, Monique, 1938-
Publicado: (1986)

Une trop bruyante solitude/
por: Hrabal, Bohumil, 1914-1997
Publicado: (1983)

Une fin trop précoce?
por: Rayson, Daniel
Publicado: (2022)

Role of mTOR Signaling in Tumor Microenvironment: An Overview
por: Conciatori, Fabiana, et al.
Publicado: (2018)

The Role of TROP2 in BCC and Cutaneous SCC: A Clinical and Immunohistochemical Study
por: Farag, Azza Gaber Antar, et al.
Publicado: (2021)

Decoding TROP2 in breast cancer: significance, clinical implications, and therapeutic advancements
por: Yao, Liqin, et al.
Publicado: (2023)

Trop‐2 cleavage by ADAM10 is an activator switch for cancer growth and metastasis
por: Trerotola, Marco, et al.
Publicado: (2021)

Should All Patients With HR-Positive HER2-Negative Metastatic Breast Cancer Receive CDK 4/6 Inhibitor As First-Line Based Therapy? A Network Meta-Analysis of Data from the PALOMA 2, MONALEESA 2, MONALEESA 7, MONARCH 3, FALCON, SWOG and FACT Trials
por: Rossi, Valentina, et al.
Publicado: (2019)

Antibody-drug conjugates targeting TROP-2: Clinical development in metastatic breast cancer
por: Shastry, Mythili, et al.
Publicado: (2022)

Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trials
por: Cuppone, Federica, et al.
Publicado: (2011)

Trop-2 in Upper Tract Urothelial Carcinoma
por: Tomiyama, Eisuke, et al.
Publicado: (2022)

Impact of epilepsy and its treatment on brain metastasis from solid tumors: A retrospective study
por: Maschio, Marta, et al.
Publicado: (2022)

Expression and clinical significance of the Trop-2 gene in advanced non-small cell lung carcinoma
por: JIANG, AIGUI, et al.
Publicado: (2013)

Correlation of TROP-2 expression with clinical–pathological characteristics and outcome in triple-negative breast cancer
por: Izci, Hava, et al.
Publicado: (2022)

Antibody-drug conjugates targeting Trop-2: Clinical developments in early breast cancer therapy
por: Jeong, Jae Ho, et al.
Publicado: (2022)

Uterine and ovarian carcinosarcomas overexpressing Trop-2 are sensitive to hRS7, a humanized anti-Trop-2 antibody
por: Raji, Rhoda, et al.
Publicado: (2011)

Epigenetically upregulating TROP2 and SLFN11 enhances therapeutic efficacy of TROP2 antibody drug conjugate sacitizumab govitecan
por: Zhao, Ming, et al.
Publicado: (2023)

Trop-2 protein as a therapeutic target: A focused review on Trop-2-based antibody-drug conjugates and their predictive biomarkers
por: Vranic, Semir, et al.
Publicado: (2022)

Trop-2 Therapy in Metastatic Triple-Negative Breast Cancer in Italy: Clinical Opportunity and Regulatory Pitfalls
por: Bravaccini, Sara, et al.
Publicado: (2021)

The Potential Diagnostic Utility of TROP-2 in Thyroid Neoplasms
por: Liu, Haiyan, et al.
Publicado: (2017)

Targeting Trop-2 in solid tumors: future prospects
por: Zaman, Saif, et al.
Publicado: (2019)

Contrôles anti-dopage : trop, pas assez, autrement ?
por: Kintz, Pascal
Publicado: (2020)

Trop2: Jack of All Trades, Master of None
por: Lenárt, Sára, et al.
Publicado: (2020)

TROP2 modulates the progression in papillary thyroid carcinoma
por: Sun, Huali, et al.
Publicado: (2021)

TROP2 Expression in Sebaceous and Sweat Gland Carcinoma
por: Ito, Takamichi, et al.
Publicado: (2022)

Trop-2 as a Therapeutic Target in Breast Cancer
por: Sakach, Elizabeth, et al.
Publicado: (2022)

Amelioration of Congenital Tufting Enteropathy in EpCAM (TROP1)-Deficient Mice via Heterotopic Expression of TROP2 in Intestinal Epithelial Cells
por: Nakato, Gaku, et al.
Publicado: (2020)

Early Progression in Non-Small Cell Lung Cancer (NSCLC) with High PD-L1 Treated with Pembrolizumab in First-Line Setting: A Prognostic Scoring System Based on Clinical Features
por: Passaro, Antonio, et al.
Publicado: (2021)

Epidemiology and clinical features of vivax malaria imported to Europe: Sentinel surveillance data from TropNetEurop
por: Mühlberger, N, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_f6dvbgph018511so4qhsvnqsfn